Tot Biopharm completes HKEX listing, raising $63M in modest debut
More than a year after closing a megaround, Tot Biopharm has closed its IPO on the Hong Kong stock exchange at a relatively modest …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
